Pregnancy and neonatal outcomes of HIV infection in pregnant women in Iran: a systematic review and meta-analysis
Open Access
- 25 November 2025
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1)
Abstract
HIV infection is a major public health concern among pregnant women globally. Beyond the risk of mother-to-child transmission, it can lead to serious complications and negative pregnancy and neonatal outcomes. In Iran, there is currently no comprehensive meta-analysis evidence measuring the adverse pregnancy and neonatal complications of HIV infection among pregnant women. The review objective is to provide pregnancy outcomes, the prevention of mother-to-child transmission (PMTCT), and antiviral therapy (ART) of pregnant women infected with HIV in Iran. The review systematically searched PubMed, Scopus, ISI, Embase, and also the Iranian national databases up to 25th September 2024. Any records that reported pregnancy and neonatal outcomes among pregnant women in Iran were included in the inclusion criteria. The study outcomes included any pregnancy and neonatal implications related to HIV infection in pregnant women, as well as PMTCT, ART therapy, delivery type, and HIV morbidity in spouse. Meta-analysis was carried out to estimate pooled prevalence with 95% confidence intervals (CIs) for all the study outcomes. The study pooled data from 497 pregnant women infected with HIV across seven eligible studies. The majority of participants had no university education, lived in urban areas, and were infected by their spouses. The most frequent adverse pregnancy outcome was abortion. The pooled proportions and 95% CIs for each outcome were: HIV-positive spouses 78% (95% CI: 73–83%), wanted pregnancy 63% (95% CI: 46–80%), ART and/or PMTCT uptake 94% (95% CI: 89–98%), cesarean delivery 88% (95% CI: 77–98%), live birth rate 98% (95% CI: 96–100%), newborns who were HIV positive 1.0% (95% CI: 0.0–1.0%), and newborn prophylaxis 100% (95% CI: 99–100%). Although most pregnant women with HIV are enrolled in PMTCT programs and adverse pregnancy and neonatal outcomes are rare, longitudinal, population-based studies are still needed to better understand the situation of pregnant women with HIV in Iran.Keywords
Funding Information
- Tabriz University of Medical Sciences (73543)
This publication has 36 references indexed in Scilit:
- Antiretroviral Treatment of HIV/AIDS During PregnancyJAMA, 2023
- The global case fatality rate due to COVID-19 in hospitalized elderly patients by sex, year, gross domestic product, and continent: A systematic review, meta-analysis, and meta-regressionNew Microbes and New Infections, 2023
- Factors associated with the reproductive health of women living with HIV in IranEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2021
- Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019The Lancet HIV, 2021
- Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysisAIDS, 2020
- Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonatesArchives of Virology, 2018
- Comparative Safety of Antiretroviral Treatment Regimens in PregnancyJAMA Pediatrics, 2017
- Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative womenAmerican Journal of Obstetrics and Gynecology, 2017
- The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic reviewJournal of Evidence-Based Medicine, 2015
- Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000–2010American Journal of Obstetrics and Gynecology, 2013